still hungry after semaglutide on Semaglutide? Understanding Why and What to Do If you’re on a GLP

Some possible healthcare-related risks of obesity include: Type 2 diabetes Heart disease and heart attacks Arthritis Gallbladder and fatty liver disease High cholesterol and high blood pressure Circulation problems and increase risks for stroke Infertility Osteoarthritis, in particular, the knees Sleep apnea and other breathing problems Certain kinds of cancer endometrial, breast, and colon Strain on bones, joints, and muscles due to increased weight Mobility issues Metabolic syndrome Emotional issues kidney disease and many others Semaglutide May Also Decrease Cardiometabolic Risks in Obese Patients Some medical experts predict that if obesity cases continue to rise, research has shown over the past three decades in the U.S., up to 50% of the population may be diagnosed with obesity by the year 2030

Diabetes Obes Metab 23(2):404414

The medication just turns down the noise and lets me make better choices

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1 Trial)

The structure-activity reasoning behind semaglutide was set out formally by Lau et al